Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -101.83% is 14% below its 5-year average of -89.33%, around the middle of its 5-year range (-155.10%–-43.53%).
18.23% above its 12-month average of -124.53%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-03-31): -29.06%.
RETURN ON ASSETS (ROA)
-101.83%
RETURN ON ASSETS (ROA) AVG TTM
-124.53%
RETURN ON ASSETS (ROA) AVG 3Y
-109.00%
RETURN ON ASSETS (ROA) AVG 5Y
-89.33%
RETURN ON ASSETS (ROA) AVG 10Y
-267.99%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.23%
CURRENT VS 3Y AVG
+6.58%
CURRENT VS 5Y AVG
-13.99%
CURRENT VS 10Y AVG
+62.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-215.85%
vs the sector median at left
Beyond Air, Inc.
Market Cap
$1.84M
Return on Assets (ROA)
-101.83%
TTM Avg
-124.53%
3Y Avg
-109.00%
5Y Avg
-89.33%
Market Cap
$1.84M
Return on Assets (ROA)
-137.72%
TTM Avg
-127.80%
3Y Avg
-167.94%
5Y Avg
-149.58%
Market Cap
$1.83M
Return on Assets (ROA)
-4123.80%
TTM Avg
-624.65%
3Y Avg
-938.33%
5Y Avg
-768.81%
Market Cap
$1.81M
Return on Assets (ROA)
-264.51%
TTM Avg
-155.32%
3Y Avg
-198.50%
5Y Avg
-155.28%
Market Cap
$1.88M
Return on Assets (ROA)
-28.33%
TTM Avg
-125.52%
3Y Avg
-210.32%
5Y Avg
-182.20%
Market Cap
$1.88M
Return on Assets (ROA)
-404.67%
TTM Avg
-168.15%
3Y Avg
-182.58%
5Y Avg
-275.93%
Market Cap
$1.64M
Return on Assets (ROA)
-75.13%
TTM Avg
-57.43%
3Y Avg
-49.05%
5Y Avg
-61.98%
Market Cap
$2.13M
Return on Assets (ROA)
-439.95%
TTM Avg
-322.44%
3Y Avg
-242.34%
5Y Avg
-192.54%
Market Cap
$2.14M
Return on Assets (ROA)
-105.97%
TTM Avg
-78.63%
3Y Avg
-114.41%
5Y Avg
-94.25%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beyond Air, Inc. (XAIR) | $1.84M | -101.83% | -124.53% | -109.00% | -89.33% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -137.72% | -127.80% | -167.94% | -149.58% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | -4123.80% | -624.65% | -938.33% | -768.81% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -264.51% | -155.32% | -198.50% | -155.28% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | -28.33% | -125.52% | -210.32% | -182.20% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | -404.67% | -168.15% | -182.58% | -275.93% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -75.13% | -57.43% | -49.05% | -61.98% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -439.95% | -322.44% | -242.34% | -192.54% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -105.97% | -78.63% | -114.41% | -94.25% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | -148.13% | -399.46% | -266.31% | -266.31% |
ROA
-101.8%
ROE
-1677.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -93.96% |
| 2025-03-31 | -155.10% |
| 2024-03-31 | -105.76% |
| 2023-03-31 | -81.19% |
| 2022-03-31 | -43.53% |
| 2021-03-31 | -56.45% |
| 2020-03-31 | -72.69% |
| 2019-03-31 | -69.56% |
| 2018-03-31 | -192.88% |
| 2016-12-31 | -1576.27% |
| 2016-06-30 | -500.47% |
| 2015-06-30 | -965.26% |
| 2013-12-31 | -852.33% |
